• Leading the Global Commercial Strategy team, including two Directors and a Senior Manager, reporting into the Chief Commercial Officer (CCO). • Oversight of commercially focused collaborations with our pharmaceutical and biotech partnerships with Boehringer Ingelheim (CT-155, CT-156), Indivior (CT-102), and Otsuka Precision Health (Rejoyn). • Leading the commercial aspects for Click Therapeutics within the cross-functional joint asset teams (JAT) for the Boehringer Ingelheim and Indivior collaborations.• Collaborating with the Business Development team on inbound and outbound interest in digital therapeutics programs with various pharmaceutical and biotech companies.• Establishing commercial due diligence and business cases for inbound and outbound business development opportunities. • Leading internal strategy and discussions around Click Therapeutics’ DiNaMo program, which focuses on establishing proof of concept for the role of prescription digital therapeutics across therapeutic areas. • Assessing potential go-to-market and portfolio opportunities for our in-development and pipeline assets. • Co-Chair on the Digital Therapeutics Alliance’s Integration & Workflow working group (April 2023 – September 2024).

• Served as the strategy lead for the US Market Access team, with a focus on developing and implementing short- and long-term strategies across public and private payer channels.• Identified current and emerging macro payer landscape trends across delivery channels and translates impact to the current and future HIV prevention and treatment markets.• Developed agile payer channel strategies that incorporates signposts for changes in management at the macroenvironmental payer and microenvironmental HIV market levels.• Partnered with cross-functional teams to identify and prioritize enterprise level opportunities and risks.• Lead internal communication around policy, payer, and environmental threats to US leadership team.• Lead the validation and deployment of the Apretude (cabotegravir LA for PrEP) Enhanced Limited Distribution Channel strategy, inclusive of roll-out to payer and field sales teams.• Developed HIV prevention-specific channel strategies in the Medicaid and Federal channels to support the overall launch strategy for Apretude.

• Served as the Market Access lead for the obesity franchise, focusing on value propositions, supporting contracting strategy, contributing to evidence generation, and engaging in lifecycle management planning.• Partnered with global teams on pre-launch activities and associated milestones for semaglutide as a pipeline asset for the treatment of obesity. • Tasked with leading annual Market Access strategy development for current and future obesity portfolio.• Collaborated with the Learning and Development team to establish and deploy a coordinated training curriculum for strategic and tactical initiatives.• Engaged with field-based colleagues within Market Access and the obesity sales organization to ensure active collaboration across teams (e.g., monthly leadership meetings, local market immersion meetings).• Lead our speaker bureau initiatives for the Novo Nordisk Inspiration Network employer speakers.

• Responsible for the development and implementation of the near and long-term market access strategies by channel for the diabetes and obesity portfolios.• Specific channel responsibilities within Market Access include commercial payers and PBMs, employers, Medicaid, state government affairs, and trade (retail and specialty pharmacy).• Tasked with leveraging industry, reimbursement, and disease area expertise to reveal new opportunities, potential threats, and mitigating actions in the market access and healthcare policy segments.• Collaborated across the home office and field-based matrix organization to accomplish goals associated with the overall organizational and market access strategies.• Lead patient affordability and lifecycle management initiatives for Market Access within Novo Nordisk.• Served on the 2017 Market Access Leadership Solutions Team, focusing on driving the business’ cultural change.

• Served as the payer marketing point on the US HCV Market Access team within the virology business unit.• Lead the development of the payer value proposition and other critical materials for the market access field team across two launches (July 2015 and February 2016).• Partnered with matrix partners on the Market Access organization (strategy and pricing teams) to receive pricing committee approval of recommended list pricing and contracting strategy for the brand.• Developed and refined customer targeting strategies for market access field teams.• Lead the development of access training materials for the market access and field sales teams.• Lead the execution of training materials through presentations/workshops at national/regional meetings.• Ensured market access and field sales teams engaged in successful pull-through of formulary wins through internal matrix team discussions and the development of customer-facing tools.• Reported weekly brand-specific data from our market access field teams and our external specialty pharmacy network for launch status updates to brand leadership.• Partnered with matrix team colleagues (e.g., professional marketing, medical, HEOR) to successfully incorporate access strategies into near-term brand planning.• Managed day-to-day operations for the US HCV Market Access team (i.e., budget, agency, vendors).• Managed promotional, medical, and legal approval process for access tools in pre- and post-launch phases.• Recipient of a Bristol-Myers Squibb Distinction Award in recognition of access work in support of Daklinza.

• Served as the lead for all US-specific access market research (e.g., health plans, pharmacy benefit managers, specialty pharmacies) in support of our cardiovascular, immunoscience, and virology portfolios.• Lead over a dozen access market research engagements, focusing on competitive market assessment, value proposition development/refinement, pricing strategy development/validation, market segmentation, and brand performance diagnosis.• Key highlights from research included partnering with matrix team members on pre-launch activities for several assets, including market assessments, value proposition development, and pricing scenario modeling. Also, received a spot bonus for leadership in a pricing strategy consulting study for virology.

• Worked as Consultant/Senior Consultant on the Brand Access Analysis team, which conducted strategic research to examine current health plan management of inline brands, while also forecasting how near-term market events and new competition would contribute to future pharmacy and medical management.• Lead our cardiovascular, endocrinology, infectious disease, and respiratory disease research initiatives. Other areas of research experience include the central nervous system, dyslipidemia, and urology markets.• Primary research responsibilities included creating the initial research plan, developing the research tools to address objectives/hypotheses, conducting quantitative/qualitative research, and writing the research report. • Client responsibilities included sharing research objectives, conducting on-site presentations following report release, and assisting with ad-hoc inquiries based on primary research and/or off-cycle market events.• Presented insights and opinions on specific therapeutic areas (i.e., cardiovascular, diabetes, respiratory) at several national/regional client team meetings and new brand launch meetings.• Recipient of Health Strategies Group's 2013 Excellence in Client Services award.

• Promoted to a position as an Associate Consultant for our Strategic Accounts team, which focused on analyzing evolving pharmacy management trends across the national and regional health plan landscape. • Responsibilities also included leading our initiatives to profile the most influential national and regional health plans, which pharmaceutical/biotech clients would use in training for customer-facing teams.• Focused on exploring how the landscape and care delivery models may evolve in a post-reform era. • Responsibilities in this position included developing the research tools, conducting extensive secondary research, writing the research report, conducting meetings with clients, and mentoring junior associates.

• Worked as an Analyst, then a Senior Analyst, on the syndicated and custom research teams.• Responsibilities included managing relationship between the senior project team and research operations teams, analyzing the quantitative or qualitative data through SPSS and Excel, and fulfilling client ad-hoc inquiries for both syndicated and custom research projects.

• Worked as a Research Manager for a multi-national custom research firm, focusing on consumer research. • Responsibilities included handling the day-to-day operations of individual projects, including developing internal communications with research operations, analyzing study data to develop key findings and detailed insights, and working directly with custom research clients.

• Worked as a Data Programmer, Project Associate, and then Project Director for a multi-national pharmaceutical consulting firm, specializing in health care provider primary market research.• Primary responsibilities as a Project Associate and Project Director included interfacing with outside field vendors, quality checking data in reports for accuracy, and preparing data analysis for final research reports.